Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AUTHOR REPLY.
Redmond EJ, Nadeau G, Tu LM, Doiron RC, Steele SS, Herschorn S, Locke JA, Maciejewski CC, Dwyer NT, Campeau L, Carlson KV, Rourke KF. Redmond EJ, et al. Among authors: tu lm. Urology. 2021 Feb;148:285-286. doi: 10.1016/j.urology.2020.09.049. Urology. 2021. PMID: 33549220 No abstract available.
A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study).
Staskin D, Herschorn S, Fialkov J, Tu LM, Walsh T, Schermer CR. Staskin D, et al. Among authors: tu lm. Int Urogynecol J. 2018 Feb;29(2):273-283. doi: 10.1007/s00192-017-3377-5. Epub 2017 Jun 15. Int Urogynecol J. 2018. PMID: 28620791 Free PMC article. Clinical Trial.
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
Herschorn S, Staskin D, Tu LM, Fialkov J, Walsh T, Gooch K, Schermer CR. Herschorn S, et al. Among authors: tu lm. Health Qual Life Outcomes. 2018 Apr 19;16(1):69. doi: 10.1186/s12955-018-0892-0. Health Qual Life Outcomes. 2018. PMID: 29673355 Free PMC article. Clinical Trial.
A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence.
Jankowski RJ, Tu LM, Carlson C, Robert M, Carlson K, Quinlan D, Eisenhardt A, Chen M, Snyder S, Pruchnic R, Chancellor M, Dmochowski R, Kaufman MR, Carr L. Jankowski RJ, et al. Among authors: tu lm. Int Urol Nephrol. 2018 Dec;50(12):2153-2165. doi: 10.1007/s11255-018-2005-8. Epub 2018 Oct 15. Int Urol Nephrol. 2018. PMID: 30324580 Clinical Trial.
Reply by Authors.
Doiron RC, Saavedra A, Haines T, Nadeau G, Tu LM, Morisset J, Steele S, Valiquette L, Elterman D, Maciejewski C, Rourke K. Doiron RC, et al. Among authors: tu lm. J Urol. 2019 Nov;202(5):1028. doi: 10.1097/01.JU.0000578564.28793.91. Epub 2019 Oct 9. J Urol. 2019. PMID: 31339422 No abstract available.
AUTHOR REPLY.
Brière R, Versi E, Richard PO, Gratton M, Tu LM. Brière R, et al. Among authors: tu lm. Urology. 2020 Feb;136:94. doi: 10.1016/j.urology.2019.08.065. Urology. 2020. PMID: 32033687 No abstract available.
The history of sacral neuromodulation in Canada.
Gajewski JB, Hassouna MM, Corcos J, Gray GJ, Tu LM, Dwyer N. Gajewski JB, et al. Among authors: tu lm. Can Urol Assoc J. 2020 Apr;14(4):87-90. doi: 10.5489/cuaj.6499. Epub 2020 Apr 1. Can Urol Assoc J. 2020. PMID: 32254010 Free PMC article.
70 results